Human Biosciences, Inc.

Human BioSciences, Inc. (HBS) is an FDA-regulated biotechnology manufacturer specializing in proprietary collagen-based wound care products. Founded in 1996 and headquartered in Gaithersburg, Maryland, HBS develops, manufactures, and distributes advanced wound healing solutions utilizing its proprietary Kollagen™ technology—100% native, non-hydrolyzed Type I bovine collagen engineered to support all four phases of wound healing. The company's core product portfolio includes SkinTemp® II collagen dressings, Medifil® II collagen particles, and Collatek® collagen gel, indicated for burns, diabetic ulcers, surgical wounds, and chronic wounds. HBS also manufactures veterinary collagen products under the Kollavet™ brand. Beyond branded products, HBS operates a full contract manufacturing division offering private label production, custom formulation, and contract research services (including 510(k) and PMA submissions) for medical-device and consumer-product manufacturers. The company serves hospitals, wound care clinics, healthcare professionals, and veterinary practitioners through a global distribution network and maintains in-house clinical education and regulatory expertise.